Learn
What is MDMA? This psychedelic is showing promise as a treatment for PTSD and depression....
Algernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to help rebuild synaptic connections....
What is psilohuasca? This psychedelic combo marries MAO inhibitors with psilocin for an extended journey into healing....
Research into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects is getting FDA approval....
Could psychedelics help people suffering from color blindness? New research sees great potential with lsd and psilocybin....
Treating traumatic brain injury with psychedelics will get a closer study in a partnership between the World Boxing Council and...
In honor of Pride Month, Silo Wellness is launching its first-ever LGBTQIA+ psychedelic retreat in Jamaica....
In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression....
This week in psychedelic business news: Therapeutic uses of salvinorin A, a 5-MeO-DMT retreat, and World Boxing Council explores psychedelics....
New hope for PTSD sufferers as a study found a more than 60% success rate after taking MDMA in a...